Article
Cysteamine as a Future Intervention in Cystic Fibrosis Against Current and Emerging Pathogens: A Patient-based ex vivo Study Confirming its Antimicrobial and Mucoactive Potential in Sputum.
EBioMedicine - 1 Oct 2015
Devereux Graham, Fraser-Pitt Douglas, Robertson Jennifer, Devlin Edward, Mercer Derry, O'Neil Deborah
Abstract excerpt
BACKGROUND: Cysteamine has recently been shown to have in vitro properties potentially therapeutically beneficial in cystic fibrosis (CF). In this study we investigated the antimicrobial and mucolytic activity of cysteamine against the complex biologic matrix of CF sputum. METHODS: Sputum samples were obtained from 23 CF adults. Sputum polymicrobial content after in vitro exposure to cysteamine and standard CF...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
